openPR Logo
Press release

Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

06-02-2017 02:24 PM CET | Health & Medicine

Press release from: Transparency Market Research

Dilated Cardiomyopathy Therapeutics Market

Dilated Cardiomyopathy Therapeutics Market

A new market research report has been recently published by Transparency market research, a leading market intelligence firm. The research report, titled “Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, presents a market overview, market drivers, opportunities, challenges, product segmentation, and competitive landscape. The research report also features inputs and recommendations from industry experts and professionals to help the existing as well as new players in this market in designing their business strategies.According to the research study, in 2013, the global dilated cardiomyopathy therapeutics market was valued at US$651 mn and is anticipated to decline to US$328.6 mn by the end of 2020. This market is projected to exhibit -7% CAGR between 2014 and 2020.

The growing prevalence of congestive heart failure is the only key factor that is driving the demand for dilated cardiomyopathy therapeutics; however, there are many factors that are expected to hamper the growth of this market in the forecast period. Easy availability of pacemakers, implantable cardioverter defibrillators, promising developments in gene therapy, and implantable devices such as heart pumps are the factors curbing the growth of the dilated cardiomyopathy therapeutics market. In addition, the various side effects associated with the use of dilated cardiomyopathy therapeutics and other easier therapies using devices that have negligible side effects will hold back the growth of this market in the next few years.

This 90 page report gives readers a comprehensive overview of the Dilated Cardiomyopathy Therapeutics Market. Unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/dilated-cardiomyopathy-market.html

On the basis of drug class, the global market for dilated cardiomyopathy therapeutics has been classified into aldosterone antagonists, beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin II receptor blockers. By pipeline drugs, the market has been segmented into ARRY-797, CAP-1002, MYDICAR, ixCELL-DCM, and OR-1. A detailed analysis of these segments has been presented in the research report.

The global dilated cardiomyopathy therapeutics market has been divided on the basis of geography into Europe, North America, Asia Pacific, and Rest of the World. In 2013, North America accounted for the largest share of the market owing to the growing adoption of branded drugs, and the rising occurrence of congestive heart failure. In the U.S., dilated cardiomyopathy strikes around five to eight people amongst every 100,000. Asia Pacific and the Rest of the World markets for dilated cardiomyopathy therapeutics are growing at a fast pace owing to the increasing per capita income, improving economic standards, and rising demand for generic drugs.

Get accurate market forecast and analysis on the Dilated Cardiomyopathy Therapeutics Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2293

Furthermore, the research report covers the competitive landscape of the global dilated cardiomyopathy therapeutics market including an overview of leading companies, their product portfolio, financial overview, business strategies, recent developments, and SWOT analysis. Some of the prominent players operating in the global market for dilated cardiomyopathy therapeutics are Novartis International AG, Celladon Corporation, Sanofi S.A., Vericel Corporation, AstraZeneca plc, Pfizer, Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Janssen Pharmaceuticals, Inc., and Array BioPharma, Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 here

News-ID: 561264 • Views: 282

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Dilated

Global Dilated Cardiomyopathy Market Insights, Forecast
Dilated Cardiomyopathy (DCM) refers to the cardiac hypertrophy, cannot effectively pump blood. Dilated Cardiomyopathy (DCM) is due to genetic or other disease caused by a heart disease, it respectively affect the ventricles of the heart and heart, the inferior vena chamber and the upper Chambers of the heart. The global Dilated Cardiomyopathy market is valued at 180 million US$ in 2018 and will reach 290 million US$ by the end
Dilated Cardiomyopathy Market Opportunity Analysis, 2026 – 2026
Dilated cardiomyopathy (DCM) is a condition in which the heart gets enlarged and is not able to efficiently pump blood. The reduced heart function can affect the functioning of other organs such as lungs, liver, and kidney. The heart muscles begin to dilate (stretches), which result in thinning and increased area of the chamber, further it spreads to the right ventricle and atria’s. As the heart chambers dilate, heart muscles
Dilated Cardiomyopathy Market – Global Industry Insights,2025
Dilated cardiomyopathy (DCM) is a condition in which the heart gets enlarged and is not able to efficiently pump blood. The reduced heart function can affect the functioning of other organs such as lungs, liver, and kidney. The heart muscles begin to dilate (stretches), which result in thinning and increased area of the chamber, further it spreads to the right ventricle and atria’s. As the heart chambers dilate, heart muscles
Dilated Cardiomyopathy - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H1 2017, provides an overview of the Dilated Cardiomyopathy (Cardiovascular) pipeline landscape. Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. Symptoms include Fatigue and weakness, Shortness of breath (dyspnea), lightheadedness, dizziness or fainting, persistent cough or wheezing,
Dilated Cardiomyopathy Therapeutics Market Research Report Forecast
A new market research report has been recently published by Transparency market research, a leading market intelligence firm. The research report, titled “Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, presents a market overview, market drivers, opportunities, challenges, product segmentation, and competitive landscape. The research report also features inputs and recommendations from industry experts and professionals to help the
Dilated Cardiomyopathy Therapeutics Market Company Analysis and Forecast to 2020
Dilated cardiomyopathy (DCM) is a significant cause of heart failure and a leading indication for heart transplant among children and adults across the globe. This condition is characterized by enlargement of ventricular chamber, thinning of heart walls and inability to sufficiently pump blood throughout the body. Dilated cardiomyopathy can develop at any age but is more common among people aged between 20 years to 60 years. Genetic inheritance is found